Intravenous Thrombolysis Administration 3–4.5 h After Acute Ischemic Stroke: A Retrospective, Multicenter Study

Background and Objectives: Intravenous recombinant tissue plasminogen activator (rt-PA) has been approved for acute ischemic stroke (AIS) within 3 h after onset and the treatment was then extended to 4.5 h. However, the Food and Drug Administration did not approve the indication in the expanded time...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yu-Wei, Sung, Sheng-Feng, Chen, Chih-Hung, Tang, Sung-Chun, Tsai, Li-Kai, Lin, Huey-Juan, Huang, Hung-Yu, Po, Helen L., Sun, Yu, Chen, Po-Lin, Chan, Lung, Wei, Cheng-Yu, Lee, Jiunn-Tay, Hsieh, Cheng-Yang, Lin, Yung-Yang, Yeh, Shoou-Jeng, Lien, Li-Ming, Jeng, Jiann-Shing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803783/
https://www.ncbi.nlm.nih.gov/pubmed/31681138
http://dx.doi.org/10.3389/fneur.2019.01038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803783/
https://www.ncbi.nlm.nih.gov/pubmed/31681138
http://dx.doi.org/10.3389/fneur.2019.01038

Ejemplares similares